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Abstract
Objective—To assess the level of agreement when selecting quality measures for inclusion in a
composite index of neonatal intensive care quality (Baby-MONITOR) between two panels: one
comprised of academic researchers (Delphi) and another comprised of academic and clinical
neonatologists (Clinician).
Design/Methods—In a modified Delphi process, a panel rated twenty eight quality measures.
We assessed clinician agreement with the Delphi panel by surveying a sample of forty eight
neonatal intensive care practitioners. We asked the clinician group to indicate their level of
agreement with the Delphi panel for each measure using a five- point scale (much too high,
slightly too high, reasonable, slightly too low, and much too low). In addition, we asked clinicians
to select measures for inclusion in the Baby-MONITOR based on a yes or no vote and a pre-
specified two-thirds majority for inclusion.
Results—Twenty three (47.9%) of the clinicians responded to the survey. We found high levels
of agreement between the Delphi and clinician panels, particularly across measures selected for
the Baby-MONITOR. Clinicians selected the same nine measures for inclusion in the composite
as the Delphi panel. For these nine measures, 74% of clinicians indicated that the Delphi panel
rating was ‘reasonable’.
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Conclusions—Practicing clinicians agree with an expert panel on the measures that should be
included in the Baby-MONITOR, enhancing face validity.
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INTRODUCTION
Composite indicators are being used increasingly to track provider performance in adult
health care settings (1–3). Composite indicators aggregate individual measures into a single
summary score. They can provide broad insights and trends of quality for external
benchmarking against other providers’ institutions and facilitate the tracking of quality
improvement efforts within institutions. However, the process of developing composite
indicators is complex and developers have to make choices in their construction that may
significantly influence performance ratings. Thus, a standardized and explicit approach to
indicator development is necessary and has been described elsewhere.(4;5)
Briefly, composite indicator development begins with a theoretical framework which
provides the foundation for the selection and aggregation of variables. Data selection targets
variables with strong analytical soundness, measurability, and relevance to the measured
event. Additionally, developers examine the completeness, structure, and comparability of
each selected variable, as well as the methods for weighting and aggregation. Finally,
developers evaluate uncertainty (i.e., around aggregate ranks), transparency (i.e., explaining
relative significance of individual domains), and linkages (i.e., to other indicators), and
provide coherent visual tools for interpretation.
We are working to develop a CI of quality delivered to very low birth weight infants
(VLBW), specifically the Measure Of Neonatal InTensive care Outcomes Research, or
Baby-MONITOR. In a previous study, a panel of neonatal outcome researchers utilized a
modified Delphi method to assign scores from 1–9 (9 = best) to 28 measures of quality
routinely collected at the NICU-level by the California Perinatal Quality Care Collaborative
(CPQCC) and Vermont Oxford Network (VON) (6). Based on the panel’s ratings, nine
measures were selected for inclusion in the Baby-MONITOR. It is possible that a sample of
largely academic researchers and quality improvement experts, which composed our original
panel, would have a biased view regarding quality of care measurement. We address this
concern by examining agreement between the Delphi panel’s selections of quality measures
with those of clinical providers of neonatal intensive care.
METHODS
Physician Nominations
Clinical neonatologists were nominated for study participation via executive channels within
the American Academy of Pediatrics (AAP) Section on Perinatal Pediatrics. We invited the
District Chairs from each of the ten AAP districts to provide three to four nominations of
clinical neonatologists from within their district for study participation. Nominees were
Board–certified in Neonatal Perinatal Medicine and had experience in quality improvement.
They were judged by the nominator to be respected by their peers. Nominees were selected
to create a sample that represented both public and private hospitals from a geographic
distribution throughout the districts.
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Nominees were contacted electronically. Consent was implied by those who responded with
intent to participate. The study was approved by the Baylor College of Medicine
Institutional Review Board.
Measure Selection
Details of the clinical measures and the process for selecting a candidate measure set have
been previously described (6). Briefly, 28 routinely reported process–and-outcome quality
measures were selected by consensus of a panel of quality improvement researchers. These
measures were selected from CPQCC and VON operations manuals. The selection process
was designed for inclusiveness and only excluded measures of surgical quality. For the
current study, one of the 28 previously selected measures (duration of ventilation) was
excluded because of inconsistent recording in the CPQCC database.
Survey Instrument
Participants were provided with a summary of each quality measure along with ratings from
the Delphi panel. The Delphi panel’s ratings were presented as median scores across five
measurement domains: importance, reliability, validity, scientific soundness, and usability
(rated on a scale of 1–9; 9 = best). In addition, we provided the Delphi panel’s overall
median rating.
Data Collection
Clinicians utilized the measure summary information, as well as the ratings generated by the
previous Delphi panel, to assess their level of agreement with the panel’s ratings. Clinicians
reported one measure of agreement, using a five-point scale (the measure is rated much too
high, slightly too high, reasonably, slightly too low, or much too low), to represent their
assessment of the panel’s full complement of ratings, including individual domain and
overall scores. In addition to structured multiple-choice response options, respondents
provided additional free-text feedback regarding the measure itself and their rationale for
selecting a specific response option. Following the evaluation of each measure
independently, respondents designated which of the 27 measures to incorporate into the
Baby-MONITOR. Prior to data collection, we specified that measures must receive support
from a two-thirds majority to be selected for the composite. Lastly, clinicians provided
information regarding practice setting (i.e., academic versus private; NICU-level designation
[using established criteria (7)]; years in practice; level of research participation; quality
improvement involvement; and location of medical training [e.g., foreign versus US medical
graduate]).
Statistical Evaluation
SAS version 9.2 (SAS Institute Inc., Cary, North Carolina, USA) was utilized for data
analyses. Descriptive statistics were calculated to determine the distribution of
characteristics in the Clinician panel. Additionally, frequency distributions were generated
to determine the percentage of agreement with Delphi panel ratings for each measure.
Because the information provided by the respondents was being used to determine the
appropriateness of the measures included in the BABY-Monitor, we defined “agreement” as
all ratings that did not indicate a strong divergence from the expert panel’s opinions (e.g.,
much too high/much too low). Potential differences in the reported percentage of agreement
were evaluated in comparisons of clinicians practicing in academic versus private settings,
using chi-square tests. Additional comparisons were conducted around the percentage of
agreement between measures selected versus not selected for the composite by the Delphi
panelists.
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District chairs nominated 48 neonatologists, representing all ten AAP districts. Of the 48
nominees, 30 clinicians consented to participate. At the completion of the study, 23 of the 30
participants consented had completed and submitted responses. Nominations and responses
were received over a period of nine months, from January to September 2009.
Clinician characteristics are shown in Table 1. Frequency distributions for practice setting;
years in practice since completion of subspecialty training; NICU level designation;
involvement in quality improvement; clinical research participation; and foreign medical
education are displayed. Respondents represented geographically diverse regions of the US,
including nine out of ten districts from the AAP Section on Perinatal Pediatrics. None of the
nominees from District 10, which includes Alabama, Florida, Georgia, and Puerto Rico,
provided responses. Overall, a majority of the respondents were academic clinicians (67%);
in practice for ten years or more (86%); involved in quality improvement (95%); and US
medical graduates (100%). Approximately one half of respondents reported practicing
medicine at a NICU with a Level 3C (7) subspecialty designation and participating in
clinical research as either a principal or co-investigator. Similar to respondents, a majority of
non-respondents were from academic hospitals (60%; data not shown).
Clinician Agreement
Surveyed clinicians reported a high degree of agreement with the previous Delphi panel’s
ratings (see Table 2). Overall, 62% of clinician responses across the 27 measures indicated
the ratings provided by the Delphi panel were ‘quite reasonable,’ and only 6% indicated
extreme disagreement with the Delphi panel’s ratings (‘much too high’/’much too low’).
Furthermore, the Delphi panel’s ratings for one measure, timely ROP examination, received
almost unanimous support from clinicians (96%). However, there were also measures that
engendered disagreement between the panels. The three measures with the most discordant
responses were feeding with human milk only at discharge; surfactant administration within
two hours of birth; and intracranial hemorrhage severity > grade 2. For example, clinician
opinion regarding the Delphi panel’s ratings of ‘feeding with human milk only at discharge’
was distributed across all response options, including ‘much too high’ and ‘much too low’
(‘reasonable’=46%). However, when taking into account slight agreement and disagreement,
even this most “controversial” measure achieved an overall agreement of 80%.
Appendix 1, available electronically as supplementary material, summarizes clinician
feedback regarding aspects of each of the measures assessed by the panel. On average, there
were seven comments provided for each measure. Comments were categorized by measure
definition, usability, and validity. With the exception of duplicate content, all of the clinician
comments were presented in Appendix 1.
Respondents reported several recurring criticisms of the measures under evaluation.
Frequently, clinicians indicated that patient transfers in and out of the NICU may
significantly impact inter-unit comparisons. Thus, to facilitate accurate assessments,
definitions must appropriately adjust for patient transfers. Additionally, clinicians reported
concerns about quality of care being measured on variables significantly influenced by
factors outside of their control. Furthermore, respondents expressed apprehension around the
variability in policies, practices, and techniques that may obscure comparisons between
different units. Finally, respondents suggested that several measures were susceptible to
“gaming” and that risk-adjustment models have not been sufficiently tested and validated.
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Differences by Clinician Practice Setting
Clinicians from different practice settings responded similarly to the ratings for most
measures (p>0.1). However, results indicate clinicians practicing in private settings viewed
some of the panel’s ratings differently than those practicing in academic settings. Most
notably, clinicians in private settings reported that surfactant administration was rated too
high by the research panel while those affiliated with academic institutions reported the
panel’s ratings were reasonable (p=0.05). Additionally, no private practice setting clinicians
(n=7) voted to include surfactant in the composite. Conversely, compared to academic
clinicians, those practicing in private settings tended to report that length of stay was rated
too low (p=0.06) and to include the measure in the composite indicator more frequently than
academic clinicians (p<0.1). Neither of these measures was included in the Baby-
MONITOR by the Delphi panel.
Measure Selection
The Delphi panel had selected nine measures of quality for inclusion in the Baby-
MONITOR. In the current study, we pre-specified a two-thirds majority of clinician
responses as evidence for agreement. Using this criterion, the clinicians independently
selected the same nine measures as the Delphi panel. The percentage agreement ranged from
66% to 100% across the selected measures. Clinicians reported significantly higher
agreement with the Delphi panel’s ratings across the measures included in the composite,
compared to measures not included (p<0.001). Table 3 presents the median ratings for each
of the measures selected by the Delphi panel; the percentage of clinician agreement with the
panel’s ratings; and the percentage of clinicians in favor of including the measure in the
Baby-MONITOR.
DISCUSSION
We report results from an electronic survey to assess agreement with the selection of
measures of NICU quality-of-care for inclusion in the Baby-MONITOR. Our principal
finding was a high level of agreement with the Delphi panel’s selection of measures into the
Baby-MONITOR by a sample of clinical neonatologists.
Comparative performance measurement has become a national health policy priority in an
attempt to promote better quality of care and decrease health care expenditures (8;9).
Composite indicators have become popular because they are able to summarize otherwise
complex information (5;10). However, the selection of quality measures into composite
indicators must undergo a careful vetting process in order to avoid undue bias on part of the
developers. We have undertaken a careful, explicit, and structured measure selection process
for the Baby-MONITOR (6). Results from the current study demonstrate a high degree of
agreement between the clinical neonatologists surveyed and the Delphi panel’s ratings. The
Delphi and clinical panels identified identical measure sets for the Baby-MONITOR. We,
therefore, believe this measure set to represent a state-of-the-art selection of robust measures
of neonatal intensive care quality. This measure set is based on available measures within
the CPQCC and VON consortia. These organizations include more than nine hundred
member institutions; therefore, the measure set has the potential for broad application.
The substantial agreement between the Delphi and Clinical panels among the measures
selected for the Baby-MONITOR provides powerful support for its acceptability as a
measurement tool. The panels also agreed strongly with regard to the measures least suitable
to measure NICU quality of care (e.g., VLBW volume, any intracranial hemorrhage, oxygen
at discharge), which calls into question the utility of allocating resources to modifying the
outcomes described in these measures. Lastly, the disagreement observed across measures
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with moderate ratings (e.g., only human milk at time of discharge, surfactant within two
hours of birth, severe intracranial hemorrhage) suggests that these measures may be
functional but require modifications or additional research to enhance their value as quality
measures.
Comments in Appendix 1 emphasize potential subjective weaknesses of each of the quality
measures. However, empirical evidence will be needed to assess whether changes in
measure definitions would improve ratings of measures not currently included in the Baby-
MONITOR (11). Additionally, these comments highlight the struggle involved in the
development of standardized quality measures. Inherent practice-based differences create
challenges in balancing measurement uniformity with specificity and applicability. These
factors support the utilization of longitudinal comparisons within organizations, rather than
comparisons across organizations.
Clinicians from different practice settings agreed upon most of the ratings of the Delphi
panel. Most importantly, clinicians from different practice settings reported agreement for
all measures selected for inclusion in the Baby-MONITOR. However, in our sample,
clinicians practicing in private hospitals indicated length of stay was rated too low by the
previous researcher panel, compared to clinicians from academic hospitals. There is a large
degree of variation in length of stay for VLBW newborns (12). This variation may be
explained by a variety of factors not directly associated with quality of care (e.g., financial
incentives, transfer bias) (8;13).
Clinicians also reported disagreement over the rating for surfactant administration, which
may reflect the current lack of consensus regarding surfactant utilization. Studies conducted
during the 1990’s firmly established intubation and early surfactant administration as the
best therapy for the treatment of respiratory distress syndrome in premature babies (14;15).
However, more recently there has been a movement to reduce the negative long-term effects
associated with mechanical ventilation, such as chronic lung disease and ventilator-
associated pneumonia. Specifically, researchers have evaluated the benefits of avoiding
intubation through the early use of nasal continuous positive airway pressure (16–19). A
best-practice consensus has yet to be established, potentially explaining the variation in
responses across academic and private settings.
The findings from the current study should be viewed within the context of the study design.
We collected responses from a small number of clinicians with membership in the AAP.
While the majority of the country’s neonatologists are members of AAP, our results may not
generalize to other samples. In addition, our sample size was relatively small. The survey
required time-consuming consideration and commentary that was not suitable for mass
distribution. Our final sample included fewer clinicians from the private practice setting than
intended. However, the current sample does represent a much more practice-focused group
than the initial Delphi panel. Therefore, we think the strong agreement between the clinician
and Delphi panels enhances the generalizability of our results. Overall, the Baby-MONITOR
has now undergone an extensive formal measure selection process.
CONCLUSION
Our results indicate a high level of agreement between a panel of researchers and clinical
neonatologists concerning the selection of appropriate quality measures for the Baby-
MONITOR, enhancing its face validity.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Deviation among clinicians’ responses evaluating ratings of 27 measures of NICU care
quality
Each midpoint (triangle) represents the mean rating from the clinician panel. The tails
represent +/− 1 standard deviation. Among the measures selected for the Baby-MONITOR
were those with the smallest standard deviation.
Measures not selected for the Baby-MONITOR: A. VLBW volume; B. IVH; C. Cystic
PVL; D. Assisted ventilation (AV); E. O2 at 28 days; F. O2 at discharge; G. AV at
discharge; H. Retinopathy of Prematurity Surgery; I. Any NEC; J. NEC surgery; K. Human
milk only at discharge; L. Length of stay; M. Retinopathy of Prematurity>stage 2; N. IVH
>grade 2; O. Temp 1 hour; P. Surfactant within 2 hours; Q. Steroids for chronic lung
disease; R. Mortality <28 days
Measures selected for the Baby-MONITOR: S. O2 at 36 weeks; T. Any human milk at
discharge; U. Hospital mortality; V. Hypothermia at admission; W. Pneumothorax; X.
Growth velocity; K. Antenatal steroids; Z Retinopathy of Prematurity Exam; AA. Late onset
sepsis
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 Academic 14 (66.7)
 Private 7 (33.3)
Years in Practice
 0–5 yrs 2 (9.5)
 6–10 yrs 1 (4.8)
 >10 yrs 18 (85.7)
NICU level
 3A 1 (4.8)
 3B 8 (38.1)
 3C 12 (57.1)
Involved in Quality Improvement
 Yes 20 (95.2)
 No 1 (4.8)
Research Participation
 PI/Co-PI 9 (45.0)
 Active participation 6 (30.0)
 Limited participation 5 (25.0)
Foreign Medical Graduate
 Yes 0 (0.0)
 No 21 (100.0)
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Table 3
Clinician Agreement with Research Panel Ratings and Selection of Measures for Inclusion in Composite
Indicator of NICU Quality of Care (Baby-MONITOR)
METRIC Panel Median Rating* (IQR) Clinician Agreement, % (SD) Clinician Vote, %
Antenatal steroids 9 (0) 78.3 (0.42) 95
Timely ROP exam 9 (0) 95.5 (0.43) 95
Nosocomial infection 9 (1) 77.3 (0.43) 100
Hypothermia at admission 8 (1) 78.3 (0.54) 95
Pneumothorax 8 (2) 56.5 (0.73) 66
Growth velocity 8 (2) 63.6 (0.69) 82
Oxygen at 36 weeks 7 (2) 76.2 (0.66) 77
Any human milk at discharge 7 (2) 72.7 (0.54) 82
NICU mortality during hospital stay 7 (2) 68.2 (0.63) 77
IQR – Interquartile Range; SD – Standard Deviation
*
Range 1–9, 9 is best. Clinician Agreement – % reporting metric reasonably rated
Clinician Vote – % voting in favor of metric inclusion in composite index (2/3 majority = Include)
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